Industry News
Pharmaceutical Industry News
In rare flop, Merck calls it quits on Keytruda-Lynparza combo in prostate cancer
In rare flop, Merck calls it quits on Keytruda-Lynparza combo in prostate cancer aliu Tue, 03/15/2022 - 11:04
High-risk lung cancer patients aren’t getting screened, survey shows. What can the industry do?
High-risk lung cancer patients aren’t getting screened, survey shows. What can the industry do? mwen Tue, 03/15/2022 - 10:58
After trial flop, Exelixis drops plan to pair Cabometyx with Roche’s Tecentriq in early-stage liver cancer
After trial flop, Exelixis drops plan to pair Cabometyx with Roche's Tecentriq in early-stage liver cancer fkansteiner Tue, 03/15/2022 - 10:16
Indian pharma, US plastic surgeon reach deal to build $50M drug plant in Africa
Indian pharma, US plastic surgeon reach deal to build $50M drug plant in Africa jkeenan Tue, 03/15/2022 - 09:57
Progenity starts oral biologic trial in ulcerative colitis after coming through early clinical test
Progenity starts oral biologic trial in ulcerative colitis after coming through early clinical test ntaylor Tue, 03/15/2022 - 09:53
MHRA request about ultrasound activation system holds up Exact Therapeutics’ solid tumor trial
MHRA request about ultrasound activation system holds up Exact Therapeutics’ solid tumor trial ntaylor Tue, 03/15/2022 - 09:42
Novo Nordisk adds bioelectronics, biosensors and stimuli-responsive delivery devices to scope of MIT pact
Novo Nordisk adds bioelectronics, biosensors and stimuli-responsive delivery devices to scope of MIT pact ntaylor Tue, 03/15/2022 - 09:30
Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of subcutaneous Sarclisa
Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of subcutaneous Sarclisa ntaylor Tue, 03/15/2022 - 09:04
Top Pfizer, Moderna execs at odds on need for 4th COVID-19 vaccine dose
Top Pfizer, Moderna execs at odds on need for 4th COVID-19 vaccine dose fkansteiner Tue, 03/15/2022 - 08:58
CDMO I Peace expansion triples capacity to manufacture induced pluripotent stem cells
CDMO I Peace expansion triples capacity to manufacture induced pluripotent stem cells jkeenan Tue, 03/15/2022 - 08:58
Biogen takes full control of troubled Aduhelm in revamped Eisai deal
Biogen takes full control of troubled Aduhelm in revamped Eisai deal aliu Tue, 03/15/2022 - 06:49
Incyte’s Opzelura slapped with vitiligo delay amid topical JAK’s eczema launch
Incyte's Opzelura slapped with vitiligo delay amid topical JAK's eczema launch fkansteiner Mon, 03/14/2022 - 10:31
UsAgainstAlzheimer’s, spending millions to bat for Biogen’s Aduhelm, launches TV and digital campaign
UsAgainstAlzheimer’s, spending millions to bat for Biogen’s Aduhelm, launches TV and digital campaign badams Mon, 03/14/2022 - 09:28
AstraZeneca’s Fasenra hit with FDA rejection, falling further behind GSK’s Nucala in nasal polyps
AstraZeneca's Fasenra hit with FDA rejection, falling further behind GSK's Nucala in nasal polyps aliu Mon, 03/14/2022 - 09:22
Pfizer pledges to donate all Russian profits to humanitarian causes amid war in Ukraine
Pfizer pledges to donate all Russian profits to humanitarian causes amid war in Ukraine esagonowsky Mon, 03/14/2022 - 09:11
Novartis’ Sandoz bulks up in respiratory as strategic review of the generics outfit rolls on
Novartis' Sandoz bulks up in respiratory as strategic review of the generics outfit rolls on fkansteiner Mon, 03/14/2022 - 08:29
AstraZeneca, Merck’s Lynparza snags first-in-class FDA nod for early breast cancer
AstraZeneca, Merck's Lynparza snags first-in-class FDA nod for early breast cancer aliu Mon, 03/14/2022 - 06:09
Get ready to vote: Fierce Pharma’s #FierceMadness drug name tournament is back for 2022
Get ready to vote: Fierce Pharma's #FierceMadness drug name tournament is back for 2022 badams Mon, 03/14/2022 - 05:00
It’s #FierceMadness: Zepzelca kicks Lumakras, Enspryng tops Vyvgart—and it’s over to you for the big vote
It's #FierceMadness: Zepzelca kicks Lumakras, Enspryng tops Vyvgart—and it's over to you for the big vote badams Mon, 03/14/2022 - 05:00
#FierceMadness: And then there were 32: BioMarin’s Voxzogo takes the biggest win; get voting for your Sweet 16
#FierceMadness: And then there were 32: BioMarin's Voxzogo takes the biggest win; get voting for your Sweet 16 badams Mon, 03/14/2022 - 05:00